Jim Cramer spoke on CNBC's "Mad Money Lightning Round" about Biogen Inc (NASDAQ: BIIB). He is concerned about the stock because a Baird analyst expressed his skepticism about Biogen's Alzheimer's drug.
Amgen, Inc. (NASDAQ: AMGN) is a much better company than it was six months ago, said Cramer. If it trades back to $210, he would be willing to buy it.
Cramer would sell some Caterpillar Inc. (NYSE: CAT) and buy it back at a lower price. He thinks the company isn't going to have a good quarter and he is worried about trade tariffs.
See Also: Can Tesla's Stock Continue Revving After 50% Rally?
ABIOMED, Inc. (NASDAQ: ABMD) has been de-risked and Cramer would buy the stock.
Cramer would not buy Tegna (NYSE: TGNA). He thinks it's going to be possible to buy it later at a lower price.
See more from Benzinga
- 'Fast Money Halftime Report' Traders Give Their Take On JPMorgan, EA And More
- Jon Najarian Highlights Unusual Options Activity In Biogen
- 'Fast Money Halftime Report' Picks From October 14
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.